opinion

Cheering outperformance sets a dangerous precedent

Seven managers give insights

Many questions still remain

The accelerated approval of the first new Alzheimer's treatment in almost two decades looks set to drive a new wave of biotech innovation and investment.

reboot. was created to support more dialogue on race and ethnicity, born out of a working group of financial services communications professionals.  In the latest article in our reboot. series, Mehvish Ayub, Senior Investment Strategist at State Street...

Company lifecycles

Social experience an important factor

'Light-touch’ ESG regulation would be a boon'

The case for keeping bonds in porfolios